Abstract
Objective To explore the diagnostic values of bile cytology obtained in endoscopic retrograde cholangiopancreatography （ERCP） and blood tumor markers for malignant bile duct obstruction. Methods From August 2005 to April 2009, bile cytology and blood tumor markers measurement were performed in 47 cases with bile duct obstruction, in which 39 cases were confirmed to be malignant and 8 were benign. Results Malignant cells were found in bile from 26 of 39 malignant obstruction （66. 7% ）, and serum CA19-9 was positive in 28 （71.8%）. No malignant cells were detected in bile cytology from 8 cases with benign obstruction （with a specificity of 100% ） and serum CA19-9 was negative in 7 （87.5%）. In 26 patients with cholangiocarcinoma, serum CA19-9 was positive in 18 （69. 2% ）. For bile cytology and blood tumor markers test, sensitivity of parallel combination was 89. 7%, and the specificity of serial combination was 100. 0%. Conclusion Bile cytology testing during ERCP can provide the pathological evidence for malignant bile duct obstruction. The sensitivity is improved by combination tests of bile cytology and blood tumor markers. Key words: Cholangiopancreatography, endoscopic retrograde ; Biliary tract neoplasms ; Cytology; CA19-9 antigen
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
